gremubamab: Clinical Trials

2 trials of gremubamab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow gremubamab: new trials by email Literature Review of gremubamab trials Research Report on gremubamab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
MEDI3902, Placebo - Pseudomonas Aeruginosa
Phase 2CompletedMedImmune LLC1882016-03-252021-02-04
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
MEDI3902 - Dose 1, MEDI3902 - Dose 2, MEDI3902 - Dose 3 - MEDI3902 for Prevention of P. Aeruginosa Pneumonia
Phase 1CompletedMedImmune LLC562014-09-042018-08-13

Conditions studied

Pneumonia (1)  ·  Pseudomonas Infections (1)

Sponsors

MedImmune LLC (2)

Countries

United States (2)  ·  Austria (1)  ·  Belgium (1)  ·  Croatia (1)  ·  Czechia (1)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Israel (1)  ·  Portugal (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Hasan S. Jafri, M.D. (1)  ·  Martha Hernandez-Illas, MD (1)

Results publications

PMID 36380312